patient, the type of the image and signal and the corresponding data file. The Generic Agent in turn will search for the Specific Agent – Breast image Agent , EEG Agent
Dota-Dendrimer-Trastuzumab by Magnetic Resonance Imaging (MRI) in HER2+ breast cancer cells HCC1954 in apple scaffold. Methods: HER2+ breast cancer cell, HCC-1954 was culture in 3 dimensional culture ... contrast agents…
There is no available targeted therapy or imaging agent for triple negative breast cancer (TNBC). We developed a small-sized dendrimer-based nanoparticle containing a clinical relevant MRI contrast agent…
high spatial resolution (MRI). The development of a novel targeted contrast agent for breast molecular PET and MR imaging will considerably increase sensitivity of these imaging technologies enabling significant…
shell followed by loading with Gd3+ to make novel MR imaging contrast agents. Anticancer effects and MR imaging parameters of the prepared nanoconjugate was investigated in vitro: cell toxicity, apoptosis…
weighted MRI of breast cancer, this work aimed at (1) demonstrating the potential of MnCl2-enhanced MRI to detect and characterize early small breast tumors in vivo (2) investigating ... breast cancer cells at 3.0T…
breast cancer screening by addressing the potential drawbacks of MRI. CEDM generates a high-resolution, low-energy, full-field digital mammography image and, similar to MRI, a contrast-enhanced image ... provides lesion…
gadolinium MRI contrast agent and fluorophores for imaging. While being biodegradable and nontoxic, these nano conjugates have demonstrated high efficacy in the treatment of brain and breast cancer and proven…
imaging probes (e.g., fluorophores, radioisotopes, or MRI contrast agents) to achieve multifunctionality. In particular, we have successfully developed a series of multifunctional unimolecular micelle platforms for…
cancer disease. However, one of the current challenges is considerably difficult to release therapeutic agent to target site. In this study, we modified GQD that introduced herceptin through polyethylene glycol…
cancer disease. However, one of the current challenges is considerably difficult to release therapeutic agent to target site. In this study, we modified GQD that introduced herceptin through polyethylene glycol…
image. Superparamagnetic nanoparticles have recently been used to reduce T2 and T2*, thus decreasing MR signal in areas corresponding to the location of the disease. Accumulation of these contrast agents ... breast and…
functionality, nanoparticles modified with magnetic Fe3O4 have been designed to deliver multiple components and imaging agents, diagnostics and therapies. In this study, multi-responsive microgels, which were first…
tumors (>70%) in all tumor models. We also confirmed pHPMA-ZnP-based tumor imaging in autochthonous breast tumor in rat and mouse colon cancer models. The light dependent cytotoxicity ... warrant further development of…
tumors (>70%) in all tumor models. We also confirmed pHPMA-ZnP-based tumor imaging in autochthonous breast tumor in rat and mouse colon cancer models. The light dependent cytotoxicity ... warrant further development of…
gold nanorods (GNR) and hollow gold nanoshells (HGNS) as contrast agents for optoacoustic (OA) imaging, sensing, and laser ablation. Published methodology for the synthesis and surface modifications ... lines: normal…
diagnostic method. Imaging agents targeted to biomarkers specifically expressed in particular diseases are of strong interest. Clinical imaging and quantification of neuroendocrine tumors and breast cancer lesions as…
rechallenge with other hormonal agents is a therapeutic option. Tumor hormone sensitivity is usually determined by immunohistochemistry. However, 18F-FES PET/ CT, a functional imaging targeting estrogen receptors, could…
through the integration of various imaging modalities. Additionally, the review covers the integration of therapeutic agents such as chemotherapeutic drugs, gene therapies, and photothermal agents onto graphene-based…
utilizes receptor-targeted IONPs to carry single or multiple therapeutic agents for drug delivery and optical and magnetic resonance imaging (MRI). Our theranostic nanoparticles are designed to overcome physical…
flow. We showed several vascular mediators can augment EPR effect such as NO releasing agents and ACE-inhibitor (eg. enalapril) which potentiates bradykinin. They not only restore vascular flow ... fluorescent…
area of study in nanotechnology, due to its wide applications in biomedical, industrial, cell imaging and biosensor fields. The present study reports the novel green synthesis of stable ... lebbeck stem bark extracts as…
Metastatic breast cancer; Integrative imaging; Bone metastases Conflict of Interest None. References [1] Perelli F, Turrini I, Giorgi MG, Renda I and Vidiri A, et al. (2022). Contrast agents during
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.